AdvanCell, a clinical-stage radiopharmaceutical company developing innovative targeted alpha therapies for cancer, today announced that updated clinical results from the Phase 1b TheraPb trial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results